You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Global Biopharmaceuticals Market Research Report
show morePRODUCT TITLE | PUBLISHED | |
---|---|---|
Biosimilars Biosimilars and Chromatography, E-Clinical Trial... |
Upcoming | |
Recombinant Non-Glycosylated Proteins Recombinant Non-Glycosylated Proteins and Recombinant Glycosylated Proteins and |
Upcoming | |
Recombinant Glycosylated Proteins Recombinant Glycosylated Proteins and Recombinant Non-Glycosylated Proteins and |
Upcoming | |
Recombinant Peptides Recombinant Peptides and Recombinant Non-Glycosylated Proteins and |
Upcoming | |
Insulin Insulin and Recombinant Human Growth Hormone (RHGH), |
Upcoming | |
Recombinant Human Growth Hormone (RHGH) Recombinant Human Growth Hormone (RHGH) and Insulin, |
Upcoming | |
Granulocyte Colony-Stimulating Factor (Filgrastim) Granulocyte Colony-Stimulating Factor (Filgrastim) and Insulin, |
Upcoming | |
Interferon Biosimilars Interferon Biosimilars and Insulin, Recombinant Human... |
Upcoming | |
Erythropoietin (EPO) Erythropoietin (EPO) and Monoclonal Antibodies (MAB) and |
Upcoming | |
Monoclonal Antibodies (MAB) Monoclonal Antibodies (MAB) and Erythropoietin (EPO) and |
Upcoming | |
Follitropin Follitropin and Erythropoietin (EPO) and Monoclonal... |
Upcoming | |
Glucagon Glucagon and Calcitonin adds up to total Recombinant Peptides... |
Upcoming | |
Calcitonin Calcitonin and Glucagon adds up to total Recombinant Peptides... |
Upcoming | |
Israel Biopharmaceuticals The Israel bio-pharma research market is expected to grow at a CAGR of 7.4% to reach USD 659.2 million by 2020. Increasing number of pharmaceutical and biotechnology start-ups, government support, availability of sufficient venture capital (VC) funds, and availability of skilled, educated, and diverse workforce are the major factors driving the Israel medical devices market. However, government regulations (such as drug pricing) are the major factors restraining the growth of this market. |
Nov 2015 |
14 reports |
Show
Biopharmaceuticals